Tetrahydrofuran → N-(4-chloro-3-(3-methylpyridin-2-yl)phenyl)-6-(trifluoromethy)-2-methylpyridine-3-carboxamide
Reaktionsgleichung
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([NH:8][C:9]([C:11]2[C:12]([CH3:21])=[N:13][C:14]([C:17]([F:20])([F:19])[F:18])=[CH:15][CH:16]=2)=[O:10])=[CH:4][C:3]=1I.[Br-].C[C:25]1[N:30]=[C:29]([Zn+])[CH:28]=[CH:27][CH:26]=1.[CH2:32]1COCC1>>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([NH:8][C:9]([C:11]2[C:12]([CH3:21])=[N:13][C:14]([C:17]([F:20])([F:19])[F:18])=[CH:15][CH:16]=2)=[O:10])=[CH:4][C:3]=1[C:25]1[C:26]([CH3:32])=[CH:27][CH:28]=[CH:29][N:30]=1Komponenten
4
Versuchsvorschrift
N-(4-Chloro-3-iodophenyl)-6-(trifluoromethyl)-2-methylpyridine-3-carboxamide (142 mg, 0.32 mmol) was used in Procedure B with 6-methyl-2-pyridylzinc bromide (1.75 mL, of a 0.5 M in THF). Purified by silica gel chromatography (5-100% Ethyl acetate/Hexanes) to yield N-(4-chloro-3-(3-methylpyridin-2-yl)phenyl)-6-(trifluoromethyl)-2-methylpyridine-3-carboxamide as a white solid: TLC Rf=0.23 (30% ethyl acetate/hexanes); NMR (CDCl3, 400 MHz) δ 8.81 (bs, 1H), 7.95 (dd, 1H), 7.67 (m, 3H), 7.53 (t, 2H), 7.38 (d, 1H), 7.07 (d, 1H), 2.71 (s, 3H), 2.43 (s, 3H); MS (Q1) 406.1 (M)+.
Aufarbeitung
- customPurified by silica gel chromatography (5-100% Ethyl acetate/Hexanes)
Quellen und Nachweise
- ORD-Eintrag
- ord-841e9f733a1c4d2fb402682227869dff
- Quelldatensatz
- uspto-grants-2016_04
- Patentnummer
- US09321761B2
Notizen zur Reaktion
Wird geladen…